Managing treatment
Managing Expectations on Mounjaro: What to Expect, Month by Month
Mounjaro produced some of the largest average weight losses ever recorded in obesity trials, and that is exactly why expectations need managing. Averages take 72 weeks to build, they hide slow starters and non-responders, and the first month often tells you very little. This guide sets out what genuinely tends to happen at each stage, what the trial data does and does not promise, and how to judge your own progress fairly.
Key facts
- In the main licensing trial, SURMOUNT-1, adults without diabetes lost on average about 15% of their body weight on the 5 mg dose and about 21% on the 15 mg dose, but that was measured after 72 weeks, not 72 days.
- The first four weeks are spent on the 2.5 mg starting dose, which exists to settle your gut rather than to drive weight loss. A quiet first month is normal.
- Losing roughly 0.5 to 1 kg (1 to 2 lb) a week after titration is a strong, sustainable rate. A fast early drop is often partly water and usually slows.
- Averages hide individuals. Around 1 in 10 people on the top dose in the trial still lost less than 5% of their body weight, and some people respond far better than average.
- Plateaus are part of the pattern, not proof of failure, and stopping treatment without changed habits usually leads to regain. Judge progress over months, not weeks.
A realistic timeline
No two people follow the same curve, and your dose schedule, starting weight, activity and genetics all move it. With that said, this is the shape most people describe, and it matches how the trials were run.
| Stage | What commonly happens |
|---|---|
| Weeks 1 to 4 (2.5 mg) | Appetite quietens and food noise fades for many, though not all. Any early drop on the scales often includes water and glycogen rather than fat. Some people lose nothing yet; the starting dose is about tolerability. |
| Weeks 5 to 12 (stepping up) | Doses rise no faster than every four weeks. Side effects such as nausea or bowel changes tend to flare for a few days after each step, then settle. Weight loss usually becomes steadier here. |
| Months 3 to 6 | The most consistent losing phase for many people, often around 0.5 to 1 kg a week. Clothes and measurements frequently change faster than the scales. |
| Months 6 to 12 | The rate naturally slows as your body gets lighter and needs fewer calories. Short stalls of two to four weeks are common and usually break on their own. |
| Months 12 to 18 | This is where the trial averages were actually measured: roughly 15% of body weight on 5 mg and up to about 21% on 15 mg by 72 weeks. Losses flatten towards a new stable weight. |
What the trial numbers really say
The figures quoted in headlines come mainly from SURMOUNT-1, a 72-week trial of 2,539 adults with obesity but without diabetes. Average weight loss was about 15% of body weight on 5 mg, 19.5% on 10 mg and 20.9% on 15 mg, against about 3% on placebo. Around nine in ten people on the higher doses lost at least 5% of their body weight.
Three things stop those numbers being a personal promise. They are averages, so half of participants did worse than the headline and half did better. They were reached over a year and a half of continuous treatment, mostly at doses higher than many people in the UK ever use. And roughly one person in ten on the top dose still lost less than 5%, because no medicine works for everyone. If your first months look nothing like 20%, you are not behind; you are simply earlier on the curve than the headline, or on a lower dose than the trial.
Fast start or slow start, both are normal
A big first fortnight feels wonderful, but part of it is usually water. Eating less empties glycogen stores, and every gram of glycogen holds water with it, so early losses overstate fat loss and then appear to stall when that water effect is spent. The opposite pattern is just as common: nothing much for six or eight weeks, then steady movement once the dose builds. Neither start predicts your result at a year.
After titration, a loss of roughly 0.5 to 1 kg a week is not a consolation prize. It is the rate most associated with keeping muscle, keeping the weight off, and coping well with the change. Dramatic weekly numbers are neither required nor especially desirable.
Plateaus and stalls
Almost everyone stalls at some point, often around a weight the body has held before. Most stalls of a few weeks break without any change. Longer plateaus have their own causes and fixes, from dose and adherence to portion drift and muscle gain masking fat loss, and we cover them properly in the guide to why weight loss slows on Mounjaro. The expectation to set now is simple: a flat month somewhere in your journey is part of the plan, not the end of it.
The injection is not the whole job
Mounjaro changes appetite; it does not choose what you eat or move your body for you. Protein and resistance work protect muscle while you lose, sleep and stress shape hunger, and the habits you build now are what hold the result later. Our nutrition guide covers eating well on a suppressed appetite.
The clearest evidence that habits matter is what happens on stopping. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average about 14% of their body weight over the following year, while those who continued lost a further 5% or so. Expect this to work like a long-term treatment with a maintenance phase, not a short course, and if you do plan to stop, plan the habits that will take over first.
Measure more than the scales
Daily weigh-ins measure water, food in transit and hormones as much as fat. Fairer measures over a month include waist and hip measurements, progress photos in the same place and light, how clothes fit, resting heart rate, energy and sleep. Weigh weekly at the same time of day if the scales help you, and skip them if they do not. The free Augo app is built for exactly this, locking progress photos to that day’s weight and flagging genuine plateaus, and our tracker app guide compares the alternatives. If you want company from people at the same stage, the Monjour forum is free and UK-based.
Common questions
How much weight will I lose in the first month on Mounjaro?
Often little, and sometimes none, because the first four weeks are spent on the 2.5 mg starting dose, which is there for tolerability. Some people lose a few kilograms early, partly water. Neither pattern predicts your longer-term result.
I have lost a lot of weight in the first couple of weeks. Is that normal?
Yes, some people drop several kilograms very quickly, especially with a higher starting weight. Part of that early loss is water rather than fat: eating less empties glycogen stores, and glycogen is stored with water. It is nothing to worry about, but expect the pace to settle, and tell your prescriber if you are struggling to eat or drink enough.
Why have I stopped losing after a fast start?
Early losses include water released as glycogen stores empty, so the rate naturally settles once that effect is spent. Short stalls usually break on their own; longer plateaus are covered in our guide to why weight loss slows.
Is losing 1 to 2 lb a week on Mounjaro enough?
Yes. Roughly 0.5 to 1 kg a week after titration is the rate most linked with keeping muscle and keeping the weight off. Over a year it adds up to the kind of totals the trials reported.
Why has my weight jumped up overnight?
A day-to-day rise is almost always water, not fat: a salty or carb-heavy meal, hormones, hard exercise or a change in bowel habit can each swing the scales by a kilogram or more. Judge your trend over a week or two, not a single morning.
What if I am not losing weight on Mounjaro at all?
Give the medicine until you have spent several weeks at an effective dose before judging it, and check portions, alcohol and adherence honestly. If nothing has moved after that, speak to your prescriber: around one person in ten in the trials lost under 5% even at the top dose, and there are other options to discuss.
Will I regain the weight if I stop Mounjaro?
Without changed habits, most people regain much of it: in SURMOUNT-4, stopping after 36 weeks led to an average regain of about 14% of body weight over the following year. Treat stopping as something to plan with your prescriber, not an afterthought.
Sources
- Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine, 2022.
- Aronne LJ et al. Continued treatment with tirzepatide for maintenance of weight reduction (SURMOUNT-4). JAMA, 2024.
- Medicines and Healthcare products Regulatory Agency. MHRA authorises tirzepatide for weight management and weight loss. GOV.UK, 2023.
- Medicines and Healthcare products Regulatory Agency, via the electronic medicines compendium. Mounjaro: Summary of Product Characteristics, sections 4.2 and 4.8.
Monj is an independent price information service operated by Medstack Ltd. It does not sell, prescribe or supply medicines and does not give medical advice. Dosing, plateaus and stopping treatment are decisions for you and your prescriber. Report suspected side effects through the MHRA Yellow Card scheme.
